News Releases

Keyword Search

Date Title
05/11/2023 Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2023 and Highlights Recent Corporate Updates
05/04/2023 Heron Therapeutics to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
04/20/2023 Heron Therapeutics Announces Commercial Leadership Changes
04/17/2023 Heron Therapeutics Announces Presentation at 22nd Annual Needham Virtual Healthcare Conference
04/03/2023 Heron Therapeutics Announces New CEO and Board Chairman
03/23/2023 Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Highlights Recent Corporate Updates
03/13/2023 Heron Therapeutics Announces Centers for Medicare & Medicaid Services (CMS) Granted Pass-through Payment Status for APONVIE™, Effective April 1, 2023
03/10/2023 Heron Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 23, 2023
03/06/2023 Heron Therapeutics Announces U.S. Commercial Launch of APONVIE™ for the Management of Postoperative Nausea and Vomiting in Adults
02/27/2023 Heron Therapeutics Announces Presentation at 43rd Annual Cowen Healthcare Conference
Displaying 1 - 10 of 12
Print Page

Sign-Up for Email Updates

Receive news and updates on Heron’s latest innovations.